Bionoid Pharma, Inc. Moves to Expand E-Commerce Presence With Binding Agreement to Acquire Platform From Vitawin Supplements Ltd.
Bionoid Pharma (OTC PINK:BINP) has signed a Binding Letter of Intent (LOI) to acquire PrimeEnduro.com, an e-commerce platform, from Vitawin Supplements The acquisition will be structured as an Asset Purchase Agreement (APA), with Bionoid retaining all revenue generated by PrimeEnduro.com prior to the APA finalization. The company plans to integrate its AI Maverick technology into the platform to provide personalized health assistants and enhance the shopping experience. This strategic move aims to expand Bionoid's presence in the health and wellness sector through an AI-enhanced e-commerce ecosystem.
Bionoid Pharma (OTC PINK:BINP) ha firmato una Lettera d'Intenti Vincolante (LOI) per acquisire PrimeEnduro.com, una piattaforma di e-commerce, da Vitawin Supplements. L'acquisizione sarà strutturata come un Accordo di Acquisto di Attività (APA), con Bionoid che manterrà tutti i ricavi generati da PrimeEnduro.com prima della finalizzazione dell'APA. L'azienda prevede di integrare la sua tecnologia AI Maverick nella piattaforma per fornire assistenti sanitari personalizzati e migliorare l'esperienza di acquisto. Questa mossa strategica mira ad espandere la presenza di Bionoid nel settore della salute e del benessere attraverso un ecosistema di e-commerce potenziato dall'AI.
Bionoid Pharma (OTC PINK:BINP) ha firmado una Carta de Intención Vinculante (LOI) para adquirir PrimeEnduro.com, una plataforma de e-commerce, de Vitawin Supplements. La adquisición se estructurará como un Acuerdo de Compra de Activos (APA), con Bionoid reteniendo todos los ingresos generados por PrimeEnduro.com antes de la finalización del APA. La empresa planea integrar su tecnología AI Maverick en la plataforma para proporcionar asistentes de salud personalizados y mejorar la experiencia de compra. Este movimiento estratégico tiene como objetivo expandir la presencia de Bionoid en el sector de la salud y el bienestar a través de un ecosistema de e-commerce potenciado por IA.
Bionoid Pharma (OTC PINK:BINP)는 Vitawin Supplements로부터 e-commerce 플랫폼 PrimeEnduro.com을 인수하기 위한 구속력 있는 의향서(LOI)를 체결했습니다. 인수는 자산 구매 계약(APA)으로 구조화되며, Bionoid는 APA 최종화 이전에 PrimeEnduro.com에서 발생하는 모든 수익을 유지하게 됩니다. 회사는 플랫폼에 AI Maverick 기술을 통합할 계획입니다 이를 통해 개인화된 건강 도우미를 제공하고 쇼핑 경험을 향상시킬 것입니다. 이 전략적 움직임은 Bionoid의 건강 및 웰니스 분야에서의 존재감을 AI 기반의 e-commerce 생태계를 통해 확장하는 것을 목표로 하고 있습니다.
Bionoid Pharma (OTC PINK:BINP) a signé une Lettre d'Intention Contraignante (LOI) pour acquérir PrimeEnduro.com, une plateforme de commerce électronique, auprès de Vitawin Supplements. L'acquisition sera structurée comme un Accord d'Achat d'Actifs (APA), Bionoid conservant tous les revenus générés par PrimeEnduro.com avant la finalisation de l'APA. L'entreprise prévoit d'intégrer sa technologie AI Maverick sur la plateforme afin de fournir des assistants santé personnalisés et d'améliorer l'expérience d'achat. Cette démarche stratégique vise à élargir la présence de Bionoid dans le secteur de la santé et du bien-être à travers un écosystème de commerce électronique renforcé par l'IA.
Bionoid Pharma (OTC PINK:BINP) hat ein verbindliches Absichtsschreiben (LOI) unterzeichnet, um PrimeEnduro.com, eine E-Commerce-Plattform, von Vitawin Supplements zu erwerben. Der Erwerb wird als Asset Purchase Agreement (APA) strukturiert, wobei Bionoid alle Einnahmen aus PrimeEnduro.com bis zur Finalisierung des APA behält. Das Unternehmen plant, seine AI Maverick-Technologie in die Plattform zu integrieren, um personalisierte Gesundheitsassistenten bereitzustellen und das Einkaufserlebnis zu verbessern. Dieser strategische Schritt zielt darauf ab, die Präsenz von Bionoid im Gesundheits- und Wellnesssektor durch ein KI-unterstütztes E-Commerce-Ökosystem auszubauen.
- Immediate revenue retention from PrimeEnduro.com operations prior to APA finalization
- Strategic expansion into e-commerce through established platform acquisition
- Integration opportunity with proprietary AI Maverick technology
- No disclosed acquisition cost or financial terms
- Deal still in LOI phase, pending final APA completion
NEW YORK, NY / ACCESSWIRE / December 12, 2024 / Bionoid Pharma, Inc. ("Bionoid") (OTC PINK:BINP) is pleased to announce the signing of a Binding Letter of Intent (LOI) with Vitawin Supplements Ltd. to acquire its premier e-commerce platform, PrimeEnduro.com. This acquisition represents a significant milestone in Bionoid's strategic plan to expand its presence in the health and wellness sector through a scalable and AI-enhanced e-commerce ecosystem.
The LOI outlines that Bionoid will retain all revenue generated by PrimeEnduro.com prior to the finalization of the Asset Purchase Agreement (APA), ensuring a seamless ownership transition and uninterrupted operations. The transaction, structured as a straightforward APA, will enable Bionoid to rapidly integrate PrimeEnduro.com into its growing portfolio, driving further growth in the e-commerce space.
"This acquisition is an exciting opportunity for Bionoid to expand our footprint in health and wellness while leveraging the power of our AI Maverick platform to deliver enhanced customer experiences," said Wayne Cockburn, CEO of Bionoid Pharma, Inc. "This marks an important step in our long-term strategy to build innovative, AI-driven solutions that foster brand loyalty and sustainable growth."
PrimeEnduro.com is poised to benefit from the integration of Bionoid's proprietary AI Maverick technology, which offers personalized health assistants and dynamic tools to enhance the shopping experience. This synergy underscores Bionoid's commitment to leading the health and wellness sector through cutting-edge technology and strategic acquisitions.
Stay connected:
Website: BionoidPhama.com
OTC Markets: BINP
About Bionoid Pharma, Inc.
Bionoid Pharma, Inc. is a health and wellness company focused on expanding revenue and brand presence through strategic acquisitions and advanced AI technology. Its five-year plan includes acquiring revenue-generating e-commerce platforms and integrating its proprietary AI Maverick system, featuring personalized health assistants and wellness-on-demand tools. BINP aims to lead in AI-driven health solutions, fostering customer loyalty, investor confidence, and sustainable growth.
For further information, contact:
Wayne Cockburn, CEO
Phone: (905) 505-0770
Email: bionoidpharma@gmail.com
SOURCE: Bionoid Pharma, Inc.
View the original press release on accesswire.com
FAQ
What is Bionoid Pharma's (BINP) acquisition target in December 2024?
How will BINP integrate AI technology with PrimeEnduro.com?
What are the revenue terms of BINP's PrimeEnduro.com acquisition?
What type of agreement has BINP signed for the PrimeEnduro.com acquisition?
